However, the standard therapy has evolved into rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP).

• 然而，标准的治疗方案已经发展到使用利妥昔单抗，环磷酰胺，多柔比星，长春新碱和强的松。